✦ LIBER ✦

Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations

✍ Scribed by Kyrklund, C

Book ID: 111726854
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 60 KB
Volume: 68
Category: Article
ISSN: 0009-9236
DOI: 10.1067/mcp.2000.111414

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carbamazepine markedly reduces serum con

Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid

✍ M. Ucar; M. Neuvonen; H. Luurila; R. Dahlqvist; P.J. Neuvonen; T. Mjörndal 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 186 KB

Plasma concentrations of active simvasta

Plasma concentrations of active simvastatin acid are increased by gemfibrozil

✍ Backman, J 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

Soybean greatly reduces valproic acid pl

Soybean greatly reduces valproic acid plasma concentrations: A food–drug interaction study

✍ Marahatta, Anu; Bhandary, Bidur; Jeong, Seul-Ki; Kim, Hyung-Ryong; Chae, Han-Jun 📂 Article 📅 2014 🏛 Springer Science and Business Media LLC 🌐 English ⚖ 791 KB

Simvastatin reduces plasma concentration

Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia

✍ I-Te Lee; Wayne Huey-Herng Sheu; Shih-Yi Lin; Wen-Jane Lee; Yuh-Min Song; Hui-Ch 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Simvastatin and plasma very-long-chain f

Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy

✍ Aad Verrips; Michèl A. A. P. Willemsen; Estela Rubio-Gozalbo; Jan De Jong; Jan A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

Simvastatin reduces plasma lipid levels

Simvastatin reduces plasma lipid levels and improves insulin action in elderly, non-insulin dependent diabetics

✍ G. Paolisso; S. Sgambato; S. Riu; A. Gambardella; M. Verza; M. Varricchio; F. D' 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 483 KB

Twelve elderly non-insulin dependent diabetic patients took part in a double-blind, cross-over, randomized study comparing simvastatin 30 mg/day and placebo. Each treatment period lasted 3 weeks and was separated by a 3 week wash-out period. At the end of each treatment period all subjects underwent